PMCF Study on the Safety of Linovera® for the Treatment of Category-I Pressure Ulcers/Injuries

NCT06183086 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 95

Last updated 2023-12-27

No results posted yet for this study

Summary

To assess the safety and performance of Linovera® in the treatment of Category- I pressure ulcers/injuries.

Conditions

  • Pressure Ulcer

Interventions

DEVICE

Linovera®

Apply Linovera® at least twice a day (recommended every 12 h) on the pressure ulcer/injury until Category-1 pressure ulcer/injury is healed or until discharge.

Sponsors & Collaborators

  • B. Braun Medical SA

    lead INDUSTRY

Principal Investigators

  • Susana Valerdiz · Hospital Universitario Central de Asturias

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-14
Primary Completion
2024-11-30
Completion
2024-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06183086 on ClinicalTrials.gov